Braidwell LP
- SEC CIK
- 0001920938
- 最新申報
- 2026/8/14
2025 年第 1 季持倉
持倉截至 2025/3/31，2025/5/15 申報。只含多頭部位，變化是跟 2024 年第 4 季比股數。
- 持股檔數
- 64
- 較 2024 年第 4 季 −9
- 總值
- $28.4 億
- 較 2024 年第 4 季 −$5.28 億 (−15.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| Guardant Health, Inc.40131MAD1 | DEBT 1.250% 2/1 | – | $2.27 億 | 8.0% | – | 新進 | – |
| NovoCure Ltd67011XAB9 | NOTE 11/0 | – | $1.37 億 | 4.8% | – | – | – |
| NBIXNeurocrine Biosciences Inc | Stock | 1,191,925 | $1.32 億 | 4.6% | +290,135+32.2% | 加碼 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 2,977,951 | $1.01 億 | 3.6% | 00.0% | 不變 | 歷史 |
| Repligen Corp759916AD1 | NOTE 1.000%12/1 | – | $9,584 萬 | 3.4% | – | – | – |
| ARGXArgenx SE | SPONSORED ADR | 160,849 | $9,520 萬 | 3.3% | +80,083+99.2% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 2,709,875 | $9,092 萬 | 3.2% | −204,089−7.0% | 減碼 | 歷史 |
| iRhythm Holdings, Inc.450056AB2 | NOTE 1.500% 9/0 | – | $8,974 萬 | 3.2% | – | 新進 | – |
| Neogenomics Inc64049MAB6 | NOTE 0.250% 1/1 | – | $8,795 萬 | 3.1% | – | – | – |
| ALGNAlign Technology Inc | COM | 530,530 | $8,428 萬 | 3.0% | +155,351+41.4% | 加碼 | 歷史 |
| Ironwood Pharmaceuticals Inc46333XAH1 | NOTE 1.500% 6/1 | – | $8,254 萬 | 2.9% | – | – | – |
| CGONCG Oncology, Inc. | COM | 3,283,317 | $8,041 萬 | 2.8% | 00.0% | 不變 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 400,744 | $7,225 萬 | 2.5% | +200,244+99.9% | 加碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $7,200 萬 | 2.5% | – | – | – |
| TMOThermo Fisher Scientific Inc. | Stock | 127,733 | $6,356 萬 | 2.2% | +37,979+42.3% | 加碼 | 歷史 |
| DHRDanaher Corp | Stock | 309,339 | $6,341 萬 | 2.2% | +309,339 | 新進 | 歷史 |
| GKOSGLAUKOS Corp | COM | 624,435 | $6,146 萬 | 2.2% | +335,559+116.2% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 840,945 | $5,964 萬 | 2.1% | +599,710+248.6% | 加碼 | 歷史 |
| IRTCiRhythm Holdings, Inc. | COM | 556,391 | $5,824 萬 | 2.0% | −149,000−21.1% | 減碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 1,540,362 | $5,755 萬 | 2.0% | 00.0% | 不變 | 歷史 |
| TMDXTransMedics Group, Inc. | COM | 854,884 | $5,752 萬 | 2.0% | −67,216−7.3% | 減碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 1,327,327 | $5,654 萬 | 2.0% | −1,520,604−53.4% | 減碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 2,458,808 | $5,409 萬 | 1.9% | +126,612+5.4% | 加碼 | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 302,410 | $4,817 萬 | 1.7% | +9,000+3.1% | 加碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $4,381 萬 | 1.5% | – | – | – |
| Immunocore Hldgs PLC45258DAB1 | NOTE 2.500% 2/0 | – | $4,377 萬 | 1.5% | – | 新進 | – |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 1,962,909 | $4,360 萬 | 1.5% | −1,489,538−43.1% | 減碼 | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 88,000 | $4,358 萬 | 1.5% | +12,700+16.9% | 加碼 | 歷史 |
| ATECAlphatec Holdings, Inc. | COM NEW | 4,259,429 | $4,319 萬 | 1.5% | +2,939+0.1% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 2,578,404 | $4,160 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 439,968 | $3,894 萬 | 1.4% | +439,968 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 3,621,344 | $3,788 萬 | 1.3% | +2,940,162+431.6% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,652,334 | $3,614 萬 | 1.3% | −446,532−21.3% | 減碼 | 歷史 |
| ADPTAdaptive Biotechnologies Corp | COM | 4,803,794 | $3,569 萬 | 1.3% | +4,803,794 | 新進 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 1,435,955 | $3,468 萬 | 1.2% | −43,711−3.0% | 減碼 | 歷史 |
| PENPenumbra Inc | COM | 110,128 | $2,945 萬 | 1.0% | −73,700−40.1% | 減碼 | 歷史 |
| BCAXBicara Therapeutics Inc. | COM | 2,162,803 | $2,818 萬 | 1.0% | +162,144+8.1% | 加碼 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 3,536,853 | $2,805 萬 | 1.0% | −1,337,000−27.4% | 減碼 | 歷史 |
| KIDSOrthopediatrics Corp | COM | 1,107,770 | $2,728 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| HROWHarrow, Inc. | COM | 956,839 | $2,545 萬 | 0.9% | +49,800+5.5% | 加碼 | 歷史 |
| Dexcom Inc252131AM9 | NOTE 0.375% 5/1 | – | $2,280 萬 | 0.8% | – | – | – |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 8,353,287 | $1,846 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| Dexcom Inc252131AK3 | NOTE 0.250%11/1 | – | $1,804 萬 | 0.6% | – | – | – |
| XNCRXencor Inc | COM | 1,655,690 | $1,762 萬 | 0.6% | +1,040,159+169.0% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 106,713 | $1,663 萬 | 0.6% | +106,713 | 新進 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 1,572,426 | $1,613 萬 | 0.6% | +424,750+37.0% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 48,690 | $1,613 萬 | 0.6% | +48,690 | 新進 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 234,500 | $1,497 萬 | 0.5% | −130,400−35.7% | 減碼 | 歷史 |
| REPLReplimune Group, Inc. | COM | 1,461,826 | $1,425 萬 | 0.5% | −15,276−1.0% | 減碼 | 歷史 |
| RGENRepligen Corp | COM | 81,656 | $1,039 萬 | 0.4% | −202,167−71.2% | 減碼 | 歷史 |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 6,622,584 | $973.5 萬 | 0.3% | +1,182,307+21.7% | 加碼 | 歷史 |
| CELCCelcuity Inc. | COM | 884,306 | $894.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 980,773 | $742.4 萬 | 0.3% | −195,400−16.6% | 減碼 | 歷史 |
| CSTLCastle Biosciences Inc | COM | 365,247 | $731.2 萬 | 0.3% | +365,247 | 新進 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 375,355 | $680.9 萬 | 0.2% | −831,234−68.9% | 減碼 | 歷史 |
| Alphatec Hldgs Inc02081GAB8 | NOTE 0.750% 8/0 | – | $579.3 萬 | 0.2% | – | – | – |
| LUNGPulmonx Corp | COM | 752,541 | $506.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MTSRMetsera, Inc. | COM | 175,000 | $476.4 萬 | 0.2% | +175,000 | 新進 | 歷史 |
| AARDAardvark Therapeutics, Inc. | COM | 500,000 | $375.5 萬 | 0.1% | +500,000 | 新進 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 1,440,499 | $361.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,472,806 | $319.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BBNXBeta Bionics, Inc. | COM | 140,000 | $171.4 萬 | 0.1% | +140,000 | 新進 | 歷史 |
| SKYESkye Bioscience, Inc. | COM NEW | 825,732 | $131.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 72,083 | $45.3 萬 | <0.1% | +72,083 | 新進 | 歷史 |
2024 年第 4 季之後清倉（22 檔）
2024 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 4 季股數 | 2024 年第 4 季市值 | 2024 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| Guardant Health, Inc.40131MAB5 | NOTE 11/1 | – | $2.26 億 | 6.7% | – |
| Nuvasive Inc670704AJ4 | NOTE 0.375% 3/1 | – | $1.13 億 | 3.4% | – |
| AVDLAvadel Pharmaceuticals PLC | Stock | 4,105,726 | $4,315 萬 | 1.3% | 歷史 |
| FNAParagon 28, Inc. | COM | 3,834,809 | $3,961 萬 | 1.2% | 歷史 |
| BNTXBioNTech SE | SPONSORED ADS | 309,865 | $3,531 萬 | 1.0% | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 1,894,439 | $2,999 萬 | 0.9% | 歷史 |
| IMTXImmatics N.V. | SHS | 3,503,965 | $2,491 萬 | 0.7% | 歷史 |
| GERNGeron Corp | COM | 7,006,315 | $2,480 萬 | 0.7% | 歷史 |
| BRKRBruker Corp | COM | 353,200 | $2,070 萬 | 0.6% | 歷史 |
| EXASExact Sciences Corp | COM | 353,000 | $1,984 萬 | 0.6% | 歷史 |
| PCVXVaxcyte, Inc. | COM | 222,424 | $1,821 萬 | 0.5% | 歷史 |
| Amphastar Pharmaceuticals IN03209RAB9 | NOTE 2.000% 3/1 | – | $1,628 萬 | 0.5% | – |
| JSPRJasper Therapeutics, Inc. | COM NEW | 714,658 | $1,528 萬 | 0.5% | 歷史 |
| CADLCandel Therapeutics, Inc. | COM | 1,600,000 | $1,389 萬 | 0.4% | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 802,100 | $1,194 萬 | 0.4% | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 1,225,448 | $682.6 萬 | 0.2% | 歷史 |
| NVRONevro Corp | COM | 1,698,768 | $631.9 萬 | 0.2% | 歷史 |
| CBLLCeribell, Inc. | COM | 210,000 | $543.5 萬 | 0.2% | 歷史 |
| Cutera Inc232109AG3 | NOTE 4.000% 6/0 | – | $261.0 萬 | 0.1% | – |
| Cutera Inc232109AD0 | NOTE 2.250% 6/0 | – | $227.2 萬 | 0.1% | – |
| PTGXProtagonist Therapeutics, Inc | COM | 20,109 | $77.6 萬 | <0.1% | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 34,094 | $65.4 萬 | <0.1% | 歷史 |